Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models
Seminars in Cancer Biology · 2025
DOI: 10.1016/j.semcancer.2024.12.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Secil Ak Aksoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bursa Uludag University, Faculty of Medicine, Department of Medical Microbiology, Bursa, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Organoids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst prognoses of all common solid cancers. For the large majority of PDAC patients, only systemic therapies with very limited efficacy are indicated. In addition, immunotherapies have not brought the advances seen in other cancer types. Several key characteristics of PDAC contribute to poor treatment outcomes, and in this review, we will discuss how these characteristics are best captured in currently available ex vivo or in vitro model systems. For instance, PDAC is hallmarked by a highly desmoplastic and immune-suppressed tumor microenvironment that impacts disease progression and therapy resistance. Also, large differences in tumor biology exist between and within tumors, complicating treatment decisions. Furthermore, PDAC has a very high propensity for locally invasive and metastatic growth. The use of animal models is often not desirable or feasible and several in vitro and ex vivo model systems have been developed, such as organotypic cocultures and tissue slices, among others. However, the absence of a full host organism impacts the ability of these models to accurately capture the characteristics that contribute to poor outcomes in PDAC. We will discuss the caveats and advantages of these model systems in the context of PDAC's key characteristics and provide recommendations on model choice and the possibilities for optimization. These considerations should be of use to researchers aiming to study PDAC in the in vitro setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bursa Uludag University, Faculty of Medicine, Department of Medical Microbiology, Bursa, Turkey.
- Ramón y Cajal Health Research Institute (IRYCIS), Biomodels and Biomodels Platform Hospital Ramón y Cajal-IRYCIS, Carretera Colmenar Km 9,100, Madrid 28034, Spain; The Biomedical Research Network in Cancer (CIBERONC), A…
- Experimental Oncology Department, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
- Acibadem Mehmet Ali Aydinlar University, Department of Medical Biotechnology, Graduate School of Health Sciences, Istanbul, Turkey.
- Department of Biology, University of Pisa, Pisa, Italy; Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
- Amsterdam UMC Location University of Amsterdam, Laboratory of Experimental Oncology and Radiobiology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology, Amsterdam, the Netherlands. Electronic address:…
Zitieren
APA
Aksoy, S. A., Earl, J., Grahovac, J., Karakas, D., Lencioni, G., Sığırlı, S., & Bijlsma, M. F. (2025). Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.12.003
Vancouver
Aksoy SA, Earl J, Grahovac J, Karakas D, Lencioni G, Sığırlı S, et al. Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2024.12.003
BibTeX
@article{Aksoy2025,
author = {Aksoy, Secil Ak and Earl, Julie and Grahovac, Jelena and Karakas, Didem and Lencioni, Giulia and Sığırlı, Sıla and Bijlsma, Maarten F},
title = {Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models},
journal = {Seminars in Cancer Biology},
year = {2025},
doi = {10.1016/j.semcancer.2024.12.003}
}
EUVIMED